# A Multiple-dose Study of LY3031207 in Healthy Participants

> **NCT01632566** · PHASE1 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 39 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Placebo
- **DRUG:** LY3031207
- **DRUG:** Celecoxib
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT01632566
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-06
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** Elevation of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in some participants.
- **Last updated:** 2019-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01632566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01632566, "A Multiple-dose Study of LY3031207 in Healthy Participants". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01632566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*